David Shaw’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-1,300
Closed -$274K – 4605
2024
Q3
$274K Buy
+1,300
New +$226K ﹤0.01% 4019
2024
Q2
– Sell
-1,300
Closed -$279K – 4646
2024
Q1
$279K Hold
1,300
– – ﹤0.01% 3760
2023
Q4
$264K Buy
+1,300
New +$211K ﹤0.01% 3791
2022
Q4
– Sell
-10,600
Closed -$1.88M – 4972
2022
Q3
$1.88M Buy
+10,600
New +$2.13M ﹤0.01% 3064
2022
Q1
– Sell
-10,000
Closed -$2.3M – 5727
2021
Q4
$2.3M Buy
+10,000
New +$2.44M ﹤0.01% 3224
2021
Q2
– Sell
-10,000
Closed -$2.07M – 4868
2021
Q1
$2.07M Buy
+10,000
New +$2.13M ﹤0.01% 2553

Other funds holding INSP

David Shaw's INSP Position: Q3 2026 in Review

David Shaw reduced its Inspire Medical Systems (INSP) stake by 17% in Q3 2026, selling an estimated $14.9M and leaving 1,221,106 shares worth $84.7M. The position accounts for 0.04% of the portfolio, ranked #519.

David Shaw first reported a position in INSP in Q3 2018 and has held it in 33 quarters since. The position peaked at $136M in Q2 2023. 308 funds tracked by Wall St. Rank hold INSP as of Q3 2026.

  • David Shaw held 1,221,106 shares of Inspire Medical Systems worth $84.7M as of Q3 2026.
  • David Shaw sold 249,356 Inspire Medical Systems shares in Q3 2026, an estimated $14.9M.
  • Inspire Medical Systems made up 0.04% of David Shaw's portfolio in Q3 2026, its #519 holding.
  • David Shaw first reported a position in Inspire Medical Systems in Q3 2018 and has held it in 33 quarters since.
  • David Shaw's Inspire Medical Systems position peaked at $136M in Q2 2023.
  • 308 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.